Shield Therapeutics Share Discussion Threads

[kmccann156] 23/3/2021 10:50

Guys just linkedin messaged Gus Rudolph who is GM for Nz and Oz. He said their marketing team are putting together product launch and they expect that to go in the next 3 months. Wouldn't give me anymore info and directed me to investor email in HQ

[kmccann156] 23/3/2021 09:43

Cheers Daveboy

[daveboy19] 23/3/2021 09:28

Australia comes under Norgine jurisdiction, so they should in theory get some revenue going in the near future and we will get news of it at some point, same as rest of Europe after negotiations have concluded later this year.

[kmccann156] 23/3/2021 09:16

Does anyone know why Sterrit left or was pushed? What really annoys me is why they didn't have a plan in place if and when fda approval was granted. Same for oz... will they wait 2 years before trying to commecialise?

[daveboy19] 23/3/2021 08:33

Yes, peaches regularly got tense when I voiced my concerns about Watts and the BOD on several occasions. Somebody just red ticked me constantly without any rationale or debate, and now they have disappeared - hopefully not dangling from a lamppost somewhere. Lesson learned, I didn't listen to my water when Sterritt departed, hey-ho. They have shown scant regard for us PI's at every juncture. Hopefully the only way is up ...

[tradertrev] 23/3/2021 08:10

The structure here nowhere near as bad as last year's raise in Verona Pharma. That was a total stitch-up of UK investors.

[weatherman] 22/3/2021 23:14

The oversubscription suggests a demand for the stock - which suggests to me a recovery in the price imo.

[smithie6] 22/3/2021 23:06

"Since the total issuance was 82% of previous shares outstanding, I wasn't diluted, and slightly increased my holding. By AIM standards that's a pretty reasonable outcome so credit to the directors"

imo you are completely wrong.

1) you got more shares because there was no competition to get extra shares !

for you as a shareholder that is negative imo

2) the dirs. did not put in a clawback provision,
& trampled all over principles of the Company Act 2006 which calls for the co. to be run for the current shareholders not for other parties that are not shareholders

& C.A.2006 calls for new shares to be issued pro rata

3) the share price is very close to the issuing price of 30p
That is not a good sign.

4) the chart is not good

recent months is a submarine gliding downwards

------

but I hope it works out for holders.
I have no position.

[mirako] 22/3/2021 22:59

After scaling back, I got 39% of the excess I applied for. In total, including the 2 for 17 entitlement, I got new shares equal to 92.5% of initial holding, so something like 37 for 40 in reality. It'd be interesting to hear what others got to understand how they scaled it back.

Since the total issuance was 82% of previous shares outstanding, I wasn't diluted, and slightly increased my holding. By AIM standards that's a pretty reasonable outcome so credit to the directors.

That said, they underestimated how much their existing shareholders were willing to stump up, and it's galling that new investors could buy in at 30p while existing shareholders got scaled back. There has to be a better way to do these things than relying on the willingness of a large shareholder (Inventages/W Health) to accept massive dilution.

[lako42] 22/3/2021 22:52

People need to realise that these Internet personalities were ramping this at £1.50. Some of them don't even post anymore.

It's utter nonsense. For someone to be able to type that a takeover offer would have to be £8 gives you all the info you need on whether to listen to these people.

Was it peachie who was shouting constantly about how good everything was when well into the £1 region?

Dyor

[kmccann156] 22/3/2021 21:37

How and why, they haven't justified commercial feasibility yet. This ramping is just crazy speculation and not beneficial to new investors reading this board.

[its the oxman] 22/3/2021 21:36

Personally just hope we enough that's positive to get us back to 70p.

[its the oxman] 22/3/2021 21:34

More like 120p tops imho and that may be being kind. Or going on managements current track record they waste the money and value trends to zilch.

[frrinvest] 22/3/2021 21:28

Takeover target of £1.80 to £2.30 is realistic. I wouldn't be surprised if they get an offer.

[reb_ban] 22/3/2021 14:58

Market is already excessively valued across the board, why would a T/O happen at such extortionate levels even with their fundamentals Hod, you are talking utter nonsense...

[tradertrev] 22/3/2021 14:45

I got 55% of what I applied for. Would have liked a few more but it broadly removes the dilution.

[knowing] 22/3/2021 14:36

Looks like most must have taken up their full entitlement as mine was cut back.

[hodhasharon] 22/3/2021 14:02

£1 would be laughed out the park. If this is a ramp, you need to understand the fundamentals. A takeover would be in the £8-£10 range.

[hodhasharon] 22/3/2021 14:01

I only got allocated a few K worth. Hope you guys got what you wanted.

[lako42] 22/3/2021 13:26

You need to provide more meat to those bones.

[36jay] 22/3/2021 13:15

STX Rumours of Take over.£1 take over possible.

[78steve] 22/3/2021 12:51

So after the dilution what's the price equivalent to now old money around 70p ? Market cap showing as 70m at present on advfn...

[kmccann156] 22/3/2021 12:48

Last few months have been brutal and it will be interestin to see if Tims contraxt is extended past April. I expect so... however some big news Coming soon?Pt20 phosphate binder?Inclusion for Pediatrics?Launch of us Sales and marketing team?Launch of Oz partnership?Approval in China with Ask PharmaExpect Market cap to x3 from here by EOY